Biotech
Voyageur Pharmaceuticals Advances Bayer Collaboration and Critical Minerals in the American Pharmaceutical Industry
When investors discuss critical minerals, they usually think about defense, energy and advanced manufacturing. Less attention is paid…
- August 2026
- July 2026
- June 2026
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
-
InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Thursday, February 6, 2025
Investor.News is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Thursday, February 6th, at 9 AM EST,…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals’ Brent Willis on the Indispensable Role of Barium
January 27, 2025 — In an enlightening interview on Investor.News, Brent Willis, President, CEO, and Director of Voyageur Pharmaceuticals…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals’ Brent Willis on Becoming First Domestically Produced Radiology Drug Company
January 24, 2025 — In a recent interview with Investor.News host Tracy Hughes, Brent Willis, President, CEO, and Director…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals Gains Momentum as a Solution to the Critical Minerals Barium Supply Challenge
Voyageur Pharmaceuticals Launches Barium Product Suite and Advances Iodine Development for Transformational 2025 Voyageur Pharmaceuticals Ltd. (TSXV: VM)…
No CommentsTracy Hughes
-
Brent Willis on Voyageur Pharmaceuticals’ Shift to Innovative Barium Contrast Formulations and an FDA Update
September 17, 2024 — In a recent interview with InvestorNews host Tracy Hughes, Brent Willis, President, CEO, and Director…
No CommentsInvestorNews
-
InvestorTalk Alert: Geoff Benic from Safety Strips Tech Corp. to host on Wednesday, September 18, 2024
Investor.News is excited to announce an upcoming InvestorTalk scheduled for tomorrow, Wednesday, September 18th, at 9 AM EST,…
No CommentsInvestorNews
-
InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Thursday, September 12, 2024
InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Thursday, September 12th, at 9 AM EST,…
No CommentsRaj Shah
-
André Larente on DIAGNOS’ Partnership with EssilorLuxottica to Expand AI Retinal Analysis and Offers Updates on Regulatory Approvals
September 09, 2024 — In a recent interview with InvestorNews host Pat Bolland, André Larente, President, CEO, and Director…
No CommentsInvestorNews
-
InvestorTalk Alert: Andre Larente from Diagnos Inc. to host on Thursday, September 5, 2024
InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Thursday, September 5th, at 9 AM EST,…
No CommentsRaj Shah
-
Voyageur’s Partnership with Rain Cage Offers the Promise of Transforming Diagnostic Imaging and Healthcare Solutions
Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development Voyageur Pharmaceuticals Ltd. (TSXV: VM)…
No CommentsInvestorNews
InvestorNews Member News
-
Voyageur Pharmaceuticals Advances Mueller Iodine Extraction Process with 99.8% Purity Results and Planned Field Pilot Testing
-
Biotech Division of Greenland Mines Announces Issuance of Patent in Canada for the Klotho Gene Therapy Platform Technology for Alzheimer’s and Aging
-
Voyageur Pharmaceuticals Announces the Engagement of Red Cloud Securities as Market Maker
-
Biotech Division of Greenland Mines Announces Australian Patent Grant for Klotho Gene Therapy Technology for Treatment of Neuromuscular Diseases
-
Voyageur Pharmaceuticals Engages Fluor to Advance Feasibility Studies for Iodine Production and Integrated Contrast Drug Manufacturing Facility
